基于COVID-19疾病严重程度和死亡率的输管决定:一项国际研究
Athanasios Chalkias1,2, Yiyuan Huang3, Anis Ismail4
1Institute for Translational Medicine and Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
根据严重性得分指导的严重COVID-19的早期输管治疗,显著降低了死亡风险. 这项研究强调了危重病患者及时机械通风的重要性.
科学领域:
- 临界护理医学 临界护理医学
- 传染性疾病 传染性疾病
- 呼吸系统医学 呼吸系统医学
背景情况:
- 对于重症COVID-19患者机械通风的最佳时间存在不确定性.
- 基于严重性标准的输管时间可能会影响患者的治疗结果.
研究的目的:
- 评估早期与晚期侵入性机械通风 (EIMV与LIMV) 对严重COVID-19死亡率的影响.
- 评估以严重性标准为指导的输管时间是否会影响30天死亡率.
主要方法:
- 未来的多中心观察性研究 (2020年2月至2022年11月) 涉及4464名需要输管治疗的住院COVID-19患者.
- 患者被分为EIMV (顺序器官衰竭评估 [SOFA] < 7或PaO2/FiO2 > 250) 和LIMV (SOFA ≥ 7和PaO2/FiO2 ≤ 250) 组.
- 使用反向治疗概率权重分析来调整混因素.
主要成果:
- 在854名输管患者中,621人 (72.7%) 接受了EIMV,233人 (27.3%) 接受了LIMV.
- 30天死亡率在EIMV组为42.2%,在LIMV组为46.6% (p=0.28).
- EIMV与30%降低30天死亡风险 (aHR 0.68;p=0.008) 和30%降低输管后死亡风险 (aHR 0.70;p=0.006) 相关.
结论:
- 以客观严重性标准为指导的早期侵入性机械通风策略与严重的COVID-19中较低的死亡率有关.
- 基于客观评估的及时输管治疗对于改善COVID-19重症患者的治疗结果至关重要.
更多相关视频
04:30Endotracheal Intubation Using a Flexible Intubation Endoscope as a Standardized Model for Safe Airway Management in Swine
Published on: August 25, 2022
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
相关概念视频
Endotracheal Intubation I: Procedure
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...
Endotracheal Intubation II: Nursing Management
1. Nursing Care of Patients Before Intubation
Before the endotracheal intubation procedure, nurses play an essential role in ensuring the process goes smoothly. The nurses must be familiar with intubation...
Pneumonia III: Complications and Assessment
Endotracheal Tube Extubation
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
